Although the global pharmaceutical industry racked up $11 billion in fines in the last three years, “Companies might well view such fines as a quite small percentage of their global revenue” according to Boston University lawyer Kevin Outterson. “If so, little has been done to change the system. The government merely recoups a portion of the financial fruit of firms’ past misdeeds.” But trust among doctors is so low that they dismiss clinical trials funded by the industry, according to a paper published in the New England Journal of Medicine.

Article →